Dr. Chia-Ying James Lin is the President and Chief Executive Officer of Amplicore. His research at the University of Michigan and the University of Cincinnati led to the scientific discovery at the heart of Amplicore’s therapies. Dr. Lin received his Ph.D. and M.S. in biomedical engineering at the University of Michigan and his B.S. in civil engineering at National Taiwan University. He started his early faculty career at the Department of Neurosurgery at the University of Michigan where he founded a spine research laboratory. He was then recruited by the University of Cincinnati to assume the Dane A. and Mary Louise Miller Endowed Chair in Biomedical Engineering. Currently, Dr. Lin holds the Mary S. .and Joseph S. Stern, Jr. Chair in Musculoskeletal Research at the University of Cincinnati, where he also serves as the Director of Orthopaedic Research Laboratories. Dr. Lin is also a serial entrepreneur. His prior venture (as a co-founder) was Tissue Regeneration Systems, Inc., whose suite of technologies was acquired by DePuy Synthes and licensed to Medtronic. His inventorship and entrepreneurship have been recognized by many prestigious honors, including 2019 J.R. Neff Award, 2019 Ohio Faculty Council Technology Commercialization Award, and 2020 Emerging Entrepreneurial Achievement Award.